Recap: Panbela Therapeutics Q4 Earnings
Recap: Panbela Therapeutics Q4 Earnings
Panbela Therapeutics (OTC:PBLA) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:10 PM.
Panbela Therapeutics（场外交易代码：PBLA）于2024年3月26日星期二下午4点10分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Panbela Therapeutics missed estimated earnings by -171.0%, reporting an EPS of $-65.9 versus an estimate of $-24.34.
Panbela Therapeutics报告每股收益为-65.9美元，未达到预期收益-171.0％，而预期为-24.34美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
过去的收益表现
Last quarter the company missed on EPS by $0.36 which was followed by a 3.0% increase in the share price the next day.
上个季度，该公司的每股收益未达到0.36美元，随后第二天股价上涨了3.0％。
To track all earnings releases for Panbela Therapeutics visit their earnings calendar here.
要追踪Panbela Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。